Middle East and Africa Kidney Disease Market to Grow at a CAGR of 5.5% to reach US$ 7,406.2 Million from 2020 to 2027

Middle East and Africa Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Diagnosis and Treatment); End User (Hospitals, Diagnostic Laboratories, and Others); and Country

  • Report Code : TIPRE00016075
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 164
Buy Now

The Middle East & Africa kidney disease market is expected to reach US$ 7,406.2 million in 2027 from US$ 4,834.1 million in 2019. The market is estimated to grow with a CAGR of 5.5% from 2020-2027.

Kidney disease means that the kidneys are damaged and cannot filter blood as they should. This damage can cause wastes to build up in your body. Diabetes and high blood pressure are the most common causes of kidney disease. There are various types of kidney diseases including kidney stones, glomerulonephritis, urinary tract infections, and others.The scope of the kidney disease market includes product, end-user, and region.

Saudi Arabia Kidney Disease Market Revenue and Forecasts to 2027 (US$ MN)

Saudi Arabia Kidney Disease Market Revenue and Forecasts to 2027 (US$ MN)
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Market Insights

Increased Prevalence of Obesity across the Region

Every country in the Middle East & Africa region is currently facing an increasing prevalence of obesity due to multiple factors. A sedentary lifestyle and unhealthy eating habits contribute majorly to obesity in an individual. Along with a lack of physical activity and mounting stress are contributing as well. According to a report ‘2018ReviewEnd-stage Renal Disease in the Middle East: A Systematic Review and Meta-analysis’, it is estimated that the annual cost for CKD and ESRD is $48 billion and $32.9 billion and is rising due to cases of obesity.As perthe report ‘Chronic Kidney Disease in Arab World: A Call for Action,’obesity is also related to CKD epidemiology since obesity appears to be an essential risk factor for CKD. The prevalence of obesity has increased over the past two decades. Over 3,000 million adults worldwide are obese. The majority of a body mass index of at least 35 among incident dialysis patients has increased by 64% over the past decade. If trends continue, 20% of all patients will initiate dialysis with this degree of obesity. In Syria, obesity was 38.2%, with the prevalence in women nearly one and half times more than in men. Obesity affects 16–50% of individuals with diabetes in the Arab world, 20–38% have hyperlipidemia, 24–46% have hypertension and, although data are incomplete, nephropathy and retinopathy rates appear to be relatively high. Moreover, in a review of obesity prevalence in the Arab world, it was concluded that one-third of Arabs are obese, and women have notably higher rates of obesity as defined by a body mass index of 30.Thus, an increase in the prevalence of obesity in the Middle East & Africa region is likely to create lucrative opportunities for market growth.

Product- Based Market Insights

Based on product,thekidney disease marketis segmented into diagnosis and treatment. The diagnosis segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period.

End-User - Based Market Insights

Based on end-user, the kidney disease market, is segmented into hospitals, diagnostic laboratories, and others. The hospitals segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period.

Middle East & Africa Kidney Disease Market, by End-User – 2019 and 2027

Middle East & Africa Kidney Disease Market, by End-User – 2019 and 2027
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Middle East and Africa Kidney Disease Market: Strategic Insights

middle-east-and-africa-kidney-disease-market
Market Size Value inUS$ 4,834.1 Million in 2019
Market Size Value byUS$ 7,406.2 Million by 2027
Growth rateCAGR of 5.5% from 2020-2027
Forecast Period2020-2027
Base Year2020
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Product launches and approvals are commonly adopted strategies by companies to expand their footprint worldwide and meet the growing demand. The players operating in the kidney disease market adopt the expansion, collaboration, and product launch strategies to enlarge customer base across the world. These strategies allow the players to maintain their brand name globally. For instance,In February 2017,Amgen received approval for its Parsabiv (Etelcalcetide) to treat secondary hyperparathyroidism in adult patients suffering from chronic kidney disease on hemodialysis. It is the first therapy that is approved the indication in about 12 years. And it is the only calcimimetic that can be administered intravenously to the patients during dialysis.

MIDDLE EAST & AFRICAKIDNEY DISEASE MARKET SEGMENTATION

By Product

  • Diagnosis
    • Blood Tests
    • Urine Tests
    • Imaging Tests
    • Others
  • Treatment
    • Dialysis
    • Others
    • Drug Class
      • ACE Inhibitors
      • Angiotensin-II Receptor Blockers
      • Diuretics
      • Others

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Others

By Country

  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa

Company Profiles

  • Abbott
  • F. Hoffmann-La Roche Ltd
  • AbbVieInc
  • Pfizer Inc
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc
  • Sysmex Corporation
  • Siemens AG
  • Amgen Inc
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product, End User, and Country

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Saudi Arabia

The List of Companies - Middle East and Africa Kidney Disease Market

  1. Abbott
  2. F. Hoffmann-La Roche Ltd
  3. AbbVieInc
  4. Pfizer Inc
  5. Teva Pharmaceutical Industries Ltd
  6. GlaxoSmithKline plc
  7. Sysmex Corporation
  8. Siemens AG
  9. Amgen Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Middle East and Africa Kidney Disease Market